Journal
ACS APPLIED NANO MATERIALS
Volume 5, Issue 4, Pages 5045-5055Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsanm.2c00068
Keywords
SARS-CoV-2 spike protein; COVID-19; potentiometric biosensor; molecular imprinting; self-assembled monolayer; protein recognition
Funding
- U.S. Department of Energy Office of Science User Facility, at Brookhaven National Laboratory [DE-SC0012704]
- Louis Morin Charitable Trust
- Weil- Lewin Foundation
Ask authors/readers for more resources
Rapid and accurate testing is crucial in controlling pandemic diseases like COVID-19. A new detection method based on nanoscale molecular imprints has been developed, allowing for rapid detection of viruses and proteins in bodily fluids. The method offers fast, sensitive, and specific detection, making it a highly effective point-of-care diagnostic platform.
Rapid, yet accurate and sensitive testing has been shown to be critical in the control of spreading pandemic diseases such as COVID-19. Current methods which are highly sensitive and can differentiate different strains are slow and cannot be conveniently applied at the point of care. Rapid tests, meanwhile, require a high titer and are not sufficiently sensitive to discriminate between strains. Here, we report a rapid and facile potentiometric detection method based on nanoscale, three-dimensional molecular imprints of analytes on a self-assembled monolayer (SAM), which can deliver analyte-specific detection of both whole virions and isolated proteins in microliter amounts of bodily fluids within minutes. The detection substrate with nanoscale inverse surface patterns of analytes formed by a SAM identifies a target analyte by recognizing its surface nano- and molecular structures, which can be monitored by temporal measurement of the change in substrate open-circuit potential. The sensor unambiguously detected and differentiated H1N1 and H3N2 influenza A virions as well as the spike proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle-East respiratory syndrome (MERS) coronavirus in human saliva with limits of detection reaching 200 PFU/mL and 100 pg/mL for the viral particles and spike proteins, respectively. The demonstrated speed and specificity of detection, combined with a low required sample volume, high sensitivity, ease of potentiometric measurement, and simple sample collection and preparation, suggest that the technique can be used as a highly effective point-of-care diagnostic platform for a fast, accurate, and specific detection of various viral pathogens and their variants.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available